Epilepsy, Partial
23
0
0
18
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
11 trials with published results (48%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
13.0%
3 terminated out of 23 trials
85.7%
-0.8% vs benchmark
65%
15 trials in Phase 3/4
61%
11 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (23)
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures
A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects
Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)
Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy